BiotechTube
Home/Macro Biologics/Michael P. Bevilacqua, M.D., Ph.D.
MP

Michael P. Bevilacqua, M.D., Ph.D.

CEO, CSO, Director & Co-Founder

Macro Biologics

Therapeutic Areas

OncologyInfectious DiseaseTrauma

Macro Biologics Pipeline

DrugIndicationPhase
Amicidin-α SurgicalPrevention of Surgical Site InfectionsPre-clinical
Amicidin-β SolutionPrevention/Treatment of Infection in Surgery & TraumaPre-clinical
Amicidin-α PFCPrevention of Infection in Prolonged Field Care (Military)Pre-clinical
Amicidin-β/EFPrevention of Infection in Traumatic Wounds & Emergency Cesarean (Global Health)Pre-clinical